Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3P1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,579
Award facts
- Contract value 100% obligated
- $38,579.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,579.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of December 30, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat multiple inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, making this a critical pharmaceutical supply for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical contract vehicle enables the company to supply an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies customers including the Defense Health Agency and U.S. Coast Guard through this comprehensive contract framework.
Quick answers
Who was awarded contract SPE2DR26F3P1Q?
SPE2DR26F3P1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F3P1Q worth?
The government has obligated $38,579 on SPE2DR26F3P1Q.
Is contract SPE2DR26F3P1Q an order under another contract?
Yes. SPE2DR26F3P1Q is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P1Q competed?
The extent of competition for SPE2DR26F3P1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award